TMCnet News

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Thursday, December 20th BSGC, LSGP, CYRX, MSWM, PRAN
[December 20, 2007]

OTCPicks.com: OTCPicks.com Daily Market Movers Digest Midday Report for Thursday, December 20th BSGC, LSGP, CYRX, MSWM, PRAN


(M2 PressWIRE Via Thomson Dialog NewsEdge)
RDATE:20122007

Our Stocks to Watch today include BigString Corporation (OTCBB: BSGC),
Lighting Science Group (OTCBB: LSGP), CryoPort, Inc. (OTCBB: CYRX),
MetaSwarm, Inc. (OTC: MSWM), Prana Biotechnology Limited (NASD: PRAN)

Visit http://www.otcpicks.com to register for our Daily Market Mover's
Digest Newsletter, and Email Stock Watch Alerts.

BIGSTRING CORPORATION (OTCBB: BSGC)

Detailed Quote: http://www.otcpicks.com/quotes/BSGC.php

Company Profile: http://www.otcpicks.com/bigstring/bigstring.htm

BigString Corporation, through its subsidiary, BigString Interactive,
Inc., provides email services. It offers BigString, which is a
Web-based, POP3 server email service solution that allows the user to
edit, recall, cancel, and erase the email, as well as insert or delete
attachments, even after the email has been sent out and opened. The
company also provides BigString Beta 2.0 that offers erasable,
recallable, and self destroying applications, non-printable and
non-forwardable emails, set time or number of views, and masquerading
to protect the sender's privacy and security. BigString Beta 2.0 also
provides spam filters, virus protection, and large-storage web-based
email accounts. The company's products include BigString Free, which
provides the features of BigString Beta 2.0, and includes 1GB of
storage and permits the user to send unlimited emails per month;
BigString Premium, which offers the features of the BigString Free
account, plus vanity domains, POP3 access using any email client, 2GB
of storage, and 30 minute video email; and BigString Business that
offers the features of the BigString Premium account, plus 10 email
accounts, 20GB of storage, global filter notification, and email
management. BigString Corporation also offers BigString Marketer Pro,
which provides an enterprise marketing software application which
allows for the sending of interactive video email commercials that can
be programmed to self-destruct at a set time; and BigString Marketer
SMB, a hosted video email marketing platform for small and medium size
businesses. The company was founded in 2003. It was formerly known as
Recall Mail Corporation and changed its name to BigString Corporation
in 2005. Bigstring Corporation is based in Red Bank, New Jersey.

BSGC News:

December 18 - BigString Corporation Launches Facebook Application
Enabling Users to Send Self-Destructing Videos

BigString Corporation (OTCBB: BSGC) has launched an application for
Facebook that enables users to record or upload videos that can be
programmed to self-destruct at a specific time or after a set number of
views. This is part of a new BigString initiative to develop social
networking messaging applications built around the company's core
technology.

The video application will allow users to send private self-destructing
video messages or to post public video messages to the recipient's
wall. Users can record a video message directly to the application or
upload a pre-existing message.

Darin Myman, President and CEO of BigString Corporation, noted that
"Video message privacy and security is very important in a world where
you can very easily find your personal videos being put up without your
permission on sites such as YouTube. Social networks such as Facebook
interface well with BigString's proprietary messaging technology. We
provide added value to websites focused on social networking, online
dating or user-generated content where protecting a user's privacy is a
major consideration."

LIGHTING SCIENCE GROUP (OTCBB: LSGP) "Up 33.33% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/LSGP.php

Lighting Science Group Corporation produces lighting products utilizing
optimized digital lighting technology. The company offers lowbay
fixtures, display lighting fixtures, standard form factor bulbs,
candles, and flashlights. It markets its products for the commercial,
industrial, and consumer lighting markets. The company sells its
products through lighting and electrical distributors; parking garage
operators; distributors in the spa, hospitality, and leisure sectors;
and retailers of energy products, as well as through its Web site.
Lighting Science Group is based in Dallas, Texas.

LSGP News:

December 20 - Lighting Science Group Helps New York Ring in the New
Year in an Illuminating Fashion

At the stroke of midnight on January 1, 2008, New Yorkers - and people
around the World - will ring in the New Year under the glow of a
brighter and more energy-efficient Times Square ball illuminated by
cutting edge Light Emitting Diode (LED) technology.

"For the first time in history, New Year's eve's most iconic image, the
Times Square Ball, will be lit by LEDs," said Govi Rao, chairman and
chief executive officer of Lighting Science Group (OTCBB: LSGP), the
company responsible for making it possible.

Lighting Science Group (LSG) was commissioned by Philips Lighting to
develop an LED lighting system to deliver the first environmentally
friendly, brighter, more responsive New Year's Eve ball, while
maintaining the core lighting elements of the old ball. The new ball is
6 feet in diameter and weighs 1,200 pounds, and consists of 9,576
Philips' LEDs and 672 of Waterford's double-cut crystals.

"Lighting Science was selected as a partner by Philips because we have
a proven track record of successfully managing very complex LED
projects from design to execution. In addition, we have unique
capabilities to design and integrate hardware and software solutions -
including optics, thermal management, power supplies and drivers - that
control LEDs and provide a completely integrated solution," said Govi
Rao.

The new ball incorporates both colored and white LEDs. The colored LEDs
were designed to consume only 1-2 Watts of energy while delivering the
same light output as last year's 40-Watt colored incandescent bulbs.

Rao continued, "LED's are the most responsive, and among the most
energy efficient lighting technologies ever created. Finding a way to
integrate the flexibility of all the ball's elements with the vision of
the lighting designers was a unique challenge for LSG. Our engineers
were able to create an integrated package that highlights all the best
features of each element, the Philips LEDs, and the Waterford Crystals,
to generate breath-taking displays, and lighting effects."

Countdown Entertainment, owners of the Time Square New Year's Eve
event, commissioned Philips Lighting and Waterford Crystal to create
the new ball. Lighting Science was hired by Philips to integrate both
companies' technologies - specifically designing, integrating and
assembling light engines to manage the ball's power and communications
signals - to guarantee that this unique structure works on queue at the
stroke of Midnight.

Lighting Science worked closely with Focus Lighting, the ball's
lighting designer, and Hudson Scenic, the ball's structural framework
designer and manufacturer, to ensure that the overall integration went
seamlessly.

"The technology platform developed by Lighting Science boasts more than
16 million vivid, vibrant, highly-saturated colors as well as billions
of possible effects," added Rao. "This New Year's Eve ball highlights
our unique capabilities in delivering high performance LED based
solutions and we are proud to help the world usher in the New Year - in
a more responsible way."

CRYOPORT INCORPORATED (OTCBB: CYRX) "Up 25.53% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CYRX.php

CryoPort, Inc. manufactures reusable cryogenic dry shippers for the
transport of biological materials. It offers three lines of reusable
cryogenic dry vapor shippers, including AR1000, DG1000, and DS650,
which are capable of maintaining cryogenic temperatures of minus 150
centigrade or less, for up to 10 days. The AR1000 is utilized primarily
in the veterinary and human assisted reproduction markets; the DG1000
is used for shipping biological material classified as dangerous goods
by IATA standards; and the DS650 is utilized for the shipment of
specimens for diagnosis, treatment, or evaluation of disease. The
company also provides biological material holders for infectious and
dangerous goods; and artificial insemination canisters for use with its
AR1000 shippers. In addition, CryoPort develops a line of disposable
dry cryogenic shippers for the transport of biological materials,
including live cell pharmaceutical products, such as cancer vaccines,
diagnostic materials, semen and embryos, infectious substances, and
other items that require continuous exposure to frozen or cryogenic
temperatures. The company offers its products for pharmaceutical
clinical trials, gene biotechnology, transport of infectious materials
and dangerous goods, pharmaceutical distribution, artificial
insemination and embryo transfer in animals, and human assisted
reproduction artificial insemination. It sells its products directly,
as well as through third party resellers, distributors, and agents in
the Americas, Europe, and Asia. The company was founded in 1999 and is
based in Lake Forest, California.

CYRX News:

December 20 - CryoPort Ships Stem Cells for Celprogen

CryoPort, Inc. (OTCBB: CYRX) announced that it has completed a
successful shipment of stem cells for Celprogen, Inc. from Southern
California to Australia utilizing the CryoPort Express Shipper.

Celprogen's CEO, Jay Sharma commented, "The CryoPort Express shipper
has provided a more secure, cost-effective alternative to dry ice as we
ship our stem cell research and therapeutic products to customers
around the world. In addition to Australia, we have successfully
utilized the CryoPort Express shipper for shipments to many diverse
locations, such as South Africa, Japan, United Kingdom and Germany and
have found the extra holding time an important hedge against delays
that may result from regulatory and custom holds."

Peter Berry, CEO of CryoPort, stated, "We are pleased to be able to
address the challenges that biotechnology companies such as Celprogen
confront as they ship high value biomaterials in the global cold chain.
These successful shipments reinforce the value of the CryoPort Express
business model in both Europe and the developing world."

METASWARM INCORPORATED (OTC: MSWM) "Up 22.22% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/MSWM.php

MetaSwarm, Inc. is headquartered in California and is focused in the
information technology industry. MetaSwarm specializes in personal and
commercial information assurance solutions, including anti-fraud,
anti-spam, and relationship analysis solutions for the Internet
e-commerce markets. Specifically, MetaSwarm products provide
applications for message management, message and website validation,
and message and website analysis for email, cell phone text messaging
(SMS), instant messaging (IM), and web pages.

MSWM News:

December 20 - Exclusive Licensee of MetaSwarm Technology in China,
Beijing InfoSure Technology Ltd., Signs Mobile Video Contract with
Henan Cable & Communication Co., Ltd.

MetaSwarm, Inc. (OTC: MSWM) announced that its exclusive licensee in
China, Beijing InfoSure Technology Ltd. (Beijing InfoSure), has signed
a contract with Henan Cable Communications Co., Ltd. (Henan Cable), a
wholly-owned subsidiary of China Cable Communications Co., Ltd. (China
Cable) whereby Beijing InfoSure will provide video content and mobile
advertisements on the Mobile Video CGTV platform in the Henan Province
of China. Henan Cable has signed an exclusive cooperation agreement
with China Mobile Henan Branch to operate mobile Video CGTV platform in
the Henan Province of China. The Henan Province is located in eastern
central China. The total population is 97.68 million. According to the
Ministry of Information Industry, there are approximately 30 million
mobile phone subscribers in the Henan Province.

Marvin Shannon, CEO of MetaSwarm, Inc., said, "The number of mobile
phone subscribers in the Henan Province provides a perspective on the
sheer size of the overall Chinese market and illustrates the perceived
value of information and communications technology (ICT). Many Chinese
spend a greater percentage of monthly income on pre-paid phone cards
than Americans spend on food. This says a lot about the perceived
importance of telecommunications in China's society. We are proud and
excited about the potential size of the contract and look forward to
working hand-in-hand with Henan Cable in developing in this exciting
market."

ABOUT BEIJING INFOSURE

Beijing InfoSure Technology Ltd. is the exclusive licensee in China of
the HyperSwarm Engine a patent pending product of MetaSwarm, Inc. Based
on the platform of the HyperSwarm Engine, Beijing InfoSure does
research, development, design, and provides anti-spam and anti-phishing
solutions as well as application services on message verification,
information personalization, etc.

PRANA BIOTECHNOLOGY LIMITED (NASD: PRAN) "Up 21.26% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PRAN.php

Prana Biotechnology was established to commercialize research into
Alzheimer's disease and other major age-related neurodegenerative
disorders. The company was incorporated in 1997 and listed on the
Australian Stock Exchange in March 2000 and listed on NASDAQ in
September 2002. Researchers at prominent international institutions
including the University of Melbourne, the Mental Health Research
Institute (Melbourne) and Massachusetts General Hospital, a teaching
hospital of Harvard Medical School, discovered Prana's technology. For
further information, visit www.pranabio.com.

PRAN News:

December 20 - Prana Provides Update on Research and Development
Programs at Annual General Meeting

Prana Biotechnology Limited (NASD: PRAN) (ASX: PBT) provided an update
of current and future activities of the Company at the Annual General
Meeting.

Chairman and CEO of Prana Biotechnology, Mr. Geoffrey Kempler, affirmed
that the PBT2 Alzheimer's Disease clinical trial continues to be on
target with trial results expected to be announced in the first quarter
of 2008.

Mr. Kempler said, "As we previously disclosed, we have completed the
dosing of all patients as scheduled without any safety or tolerability
issues identified by the independent Data Safety Monitoring Board or
the clinical investigators. We are encouraged by the way the trial has
proceeded to date and that the drug appears well tolerated. With
results imminent, and given a positive outcome, we are planning to
progress PBT2 into a larger clinical trial in 2008."

Additional Applications for PBT2: Mr. Kempler discussed the expansion
of future therapeutic targets for PBT2, including Huntington's disease
for which advantages are envisioned over current therapies. According
to Mr. Kempler, "A positive safety and tolerability outcome with PBT2
in the current trial will allow us to test PBT2 in a second disease
indication, such as Huntington's disease, for which we have very
promising pre-clinical data."

Update on Immunotherapy Program

Going further into the pipeline of activities currently being
addressed, Mr. Kempler shared on-going developments with additional
applications of Prana's technology, highlighting a novel immunotherapy
program for Alzheimer's Disease which had started in 2003. Prana's
scientists have developed monoclonal antibodies against a unique form
(a conformational epitope) of abeta which is produced as a result of
the oxidative processes central to the toxic pathway in Alzheimer's
disease. A candidate monoclonal antibody has been selected which may be
expected to commence animal trials in first quarter 2008.

The monoclonal antibodies have been designed against particular
configurations of corrupted oligomers of abeta, in an attempt to avoid
the adverse effects associated with the earliest generation of
Alzheimer's immunotherapy, which recognized all forms of abeta.

Cancer Applications of Prana's Technology

Referring to 2008 and beyond, Mr. Kempler said, "Based on strong
pre-clinical data, the Company will initiate an R&D program to develop
selected MPAC's to treat cancer. Scientists have identified particular
classes of Prana drugs from its library which are toxic to brain cancer
cells and are well tolerated in animal models."

Prana is already regarded as a pioneer in understanding the link
between metals and degenerative diseases such as Alzheimer's Disease.
Recently, several articles have appeared in prestigious cancer journals
highlighting the relationship between metals and cancer. In vivo and in
vitro studies published by independent cancer researchers shows that
PBT1, Prana's Proof of Concept MPAC, can selectively kill a variety of
cancer types.

According to Mr. Kempler, "In 2008, we hope to select a lead candidate
to enter the development pipeline. Currently we are planning to screen
our best candidates across a range of cancer types. However given that
our drugs are designed to cross the blood brain barrier, in the first
instance we have focused on brain cancer for which there is little
effective treatment. To date we have a promising compound which has
shown selective toxicity towards brain cancer cells whilst selectively
sparing healthy brain cells, unlike common chemotherapy drugs. Our
compounds have the advantage of being available orally."

Mr. Kempler pointed to the year ahead as a time of major value adding
outcomes of the Company's research and development efforts over recent
years.

ABOUT OTCPICKS.COM

OTCPicks.com is an Internet destination for investors seeking
information on smallcap and microcap companies. The web site features
companies in Profile Campaigns, Executive Interviews and Profile
Research Reports authored by our financial writers. We publish a daily
Newsletter to subscribers, and we publish our Daily Market Movers
Digest which is sent out on the M2 Presswire several times daily
highlighting hot OTC and OTCBB stocks. To feature a company on our web
site or in our daily Newsletter or Market Mover's Digest, please
contact our publisher, Brian Dean at 972-546-3740, or via email at
[email protected].

Disclaimer: Never invest in any stock featured on our site or emails
unless you can afford to lose your entire investment. This disclaimer
is to be read and fully understood before using our site, or joining
our email list. PLEASE NOTE: The OTCPicks.com employees are NOT
Registered as an Investment Advisor in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you
agree to hold OTCPicks.com, its operators owners and employees harmless
and to completely release them from any and all liability due to any
and all loss (monetary or otherwise), damage (monetary or otherwise),
or injury (monetary or otherwise) that you may incur. Neither the
information presented nor any statement or expression of opinion, or
any other matter herein, directly or indirectly constitutes a
representation by the publisher nor a solicitation of the purchase or
sale of any securities. OTCPicks.com has not been compensated by any of
the companies covered in this release. For a complete list of
disclosures go to http://www.otcpicks.com/disclosure_details.php. The
information contained herein is based on sources which we believe to be
reliable but is not guaranteed by us as being accurate and does not
purport to be a complete statement or summary of the available data.
The owner, publisher, editor and their associates are not responsible
for errors and omissions. They may from time to time have a position in
the securities mentioned herein and may increase or decrease such
positions without notice. Any opinions expressed are subject to change
without notice. OTCPicks.com encourages readers and investors to
supplement the information in these reports with independent research
and other professional advice. All information on featured companies is
provided by the companies profiled, or is available from public sources
and OTCPicks.com makes no representations, warranties or guarantees as
to the accuracy or completeness of the disclosure by the profiled
companies or the information contained herein. OTCPicks.com and its
affiliates are not registered investment advisors or a broker dealers.
OTCPicks.com has been advised that the investments in companies
profiled are considered to be high risk and use of the information
provided is at the investor's sole risk. OTCPicks.com also advises that
the purchase of such high risk securities may result in the loss of
some or all of the investment. Investors should not rely solely on the
information presented. Rather, investors should use the information
provided by the profiled companies as a starting point for doing
additional independent research on the profiled companies in order to
allow the investor to form his or her own opinion regarding investing
in the profiled companies. Factual statements made by the profiled
companies are made as of the date stated and are subject to change
without notice. Investing in micro-cap securities is highly speculative
and carries an extremely high degree of risk. It is possible that an
investor's entire investment may be lost or impaired due to the
speculative nature of the companies profiled. OTCPicks.com makes no
recommendation that the securities of the companies profiled should be
purchased, sold or held by individuals or entities that learn of the
profiled companies through OTCPicks.com. OTCPicks.com owners may or may
not hold positions in the companies that are profiled.

The information contained herein contains forward-looking information
within the meaning of Section 27A of the Securities Act of 1993 and
Section 21E of the Securities Exchange Act of 1934 including statements
regarding expected continual growth of the company and the value of its
securities. In accordance with the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995 it is hereby noted
that statements contained herein that look forward in time which
include everything other than historical information, involve risk and
uncertainties that may affect the company's actual results of
operation. Factors that could cause actual results to differ include
the size and growth of the market for the company's products, the
company's ability to fund its capital requirements in the near term and
in the long term, pricing pressures, unforeseen and/or unexpected
circumstances in happenings, pricing pressures, etc. Investing in
securities is speculative and carries risk. Past performance does not
guarantee future results.

Third Party Web Sites and Information:

OTCPicks.com and newsletter may provide hyperlinks to third party
websites or access to third party content. OTCPicks.com does not
control, endorse, or guarantee content found in such sites. You agree
that OTCPicks.com is not responsible for any content, associated links,
resources, or services associated with a third party site. You further
agree that OTCPicks.com shall not be liable for any loss or damage of
any sort associated with your use of third party content. Links and
access to these sites are provided for your convenience only.

CONTACT: Brian Dean, Publisher, OTCPicks.com
Tel: +1 972 546 3740
e-mail: [email protected]

((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
[email protected])).

Copyright 2007 M2 Communications Ltd.

[ Back To TMCnet.com's Homepage ]